VACCINEX, INC. Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vaccinex, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Vaccinex, Inc. Depreciation for the quarter ending September 30, 2024 was $24K, a 22.6% decline year-over-year.
  • Vaccinex, Inc. Depreciation for the twelve months ending September 30, 2024 was $103K, a 24.8% decline year-over-year.
  • Vaccinex, Inc. annual Depreciation for 2023 was $119K, a 42.5% decline from 2022.
  • Vaccinex, Inc. annual Depreciation for 2022 was $207K, a 22.5% increase from 2021.
  • Vaccinex, Inc. annual Depreciation for 2021 was $169K, a 45% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $119K -$88K -42.5% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
2022 $207K +$38K +22.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
2021 $169K -$138K -45% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $307K +$58K +23.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $249K +$26K +11.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $223K +$17K +8.25% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $206K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.